Unknown

Dataset Information

0

Validation of a HPLC/MS method for simultaneous quantification of clonidine, morphine and its metabolites in human plasma.


ABSTRACT: A high-performance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of morphine, morphine's major metabolites morphine-3-glucuronide and morphine-6-glucuronide, and clonidine, to support the pharmacokinetic analysis of an ongoing double-blinded randomized clinical trial that compares the use of morphine and clonidine in infants diagnosed with neonatal abstinence syndrome. Plasma samples were processed by solid-phase extraction and separated on an Inertsil ODS-3 (4 ?m) column using an 0.1% formic acid in water-0.1% formic acid in methanol gradient. Detection of the analytes was conducted in the positive multiple reaction monitoring mode. The range of quantitation was 1-1000?ng/mL for morphine, morphine-3-glucuronide and morphine-6-glucuronide, and 0.25-100?ng/mL for clonidine. Intra-day and inter-day accuracy and precision were??15% for all analytes across the quantitation range. Extraction recovery rates were??94% for morphine, ?90% for M3G, ?87% for M6G and???79% for clonidine. Matrix effect ranged from 85-94% for clonidine to 101-106% for M3G. The method fulfilled all predetermined acceptance criteria and required only 100??L of starting plasma volume. Furthermore, it was successfully applied to 30 clinical trial plasma samples.

SUBMITTER: Tang F 

PROVIDER: S-EPMC6559858 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Validation of a HPLC/MS method for simultaneous quantification of clonidine, morphine and its metabolites in human plasma.

Tang Fei F   Bada Henrietta H   Ng Chee M CM   Leggas Markos M  

Biomedical chromatography : BMC 20190320 7


A high-performance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of morphine, morphine's major metabolites morphine-3-glucuronide and morphine-6-glucuronide, and clonidine, to support the pharmacokinetic analysis of an ongoing double-blinded randomized clinical trial that compares the use of morphine and clonidine in infants diagnosed with neonatal abstinence syndrome. Plasma samples were processed by solid-phase extraction  ...[more]

Similar Datasets

| S-EPMC4494745 | biostudies-literature
| S-EPMC4641197 | biostudies-literature
| S-EPMC6017933 | biostudies-literature
| S-EPMC5145167 | biostudies-literature
| S-EPMC6110963 | biostudies-literature
| S-EPMC7531571 | biostudies-literature
| S-EPMC7443224 | biostudies-literature
| S-EPMC9756784 | biostudies-literature
| S-EPMC7313014 | biostudies-literature
| S-EPMC8153023 | biostudies-literature